Clinical trials
Phase 1/2 Lymphoma trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 4 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 8 |
| Recruiting | 7 |
| Completed | 5 |
| Active, not recruiting | 2 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cyclacel Pharmaceuticals, Inc. | 2 |
| AstraZeneca | 1 |
| BeOne Medicines | 1 |
| Bristol-Myers Squibb | 1 |
| CRISPR Therapeutics AG | 1 |
| Celgene | 1 |
| Curis, Inc. | 1 |
| CytomX Therapeutics | 1 |
| Dren Bio | 1 |
| Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma | 24 |
| Lymphoma, Non-Hodgkin | 8 |
| Leukemia | 6 |
| Recurrence | 6 |
| Neoplasms | 5 |
| Lymphoma, B-Cell | 4 |
| Hodgkin Disease | 3 |
| Immune System Diseases | 3 |
| Lymphatic Diseases | 3 |
| Lymphoproliferative Disorders | 3 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.